EP3438107
SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.10.2017EP published:
10.6.2020EP application number:
17869669.6
EPO information:
European Patent Register
Max expiry date:
16.10.2037
Title:
SUBSTITUTED QUINAZOLINE COMPOUND HAVING BLOOD-BRAIN BARRIER PENETRATION CAPABILITY
Timeline
Today
17.10.2017EP application
10.6.2020EP Publication
Owner
Name:
Weishang (Shanghai) Bio-Pharmaceutical Co., Ltd.Address:
Room E8, 3rd Floor, Building 6 No.4299 Jindu Road Minhang District, Shanghai 201108, CN
Inventor
Name:
ZHONG, WeiAddress:
Shanghai 201108, CN
Priority
Number:
201610982608Date:
8.11.2016Country:
CN
Classification
Categories:
C07D 405/14, C07D 401/12, A61K 31/517, A61P 35/00, A61P 25/28